📣 VC round data is live. Check it out!
- Public Comps
- InspireMD
InspireMD Valuation Multiples
Discover revenue and EBITDA valuation multiples for InspireMD and similar public comparables like Mentice, HeartBeam, OssDsign, Elutia and more.
InspireMD Overview
About InspireMD
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Founded
2008
HQ

Employees
86
Website
Financials (LTM)
EV
$9M
Valuation Multiples
Start free trialInspireMD Financials
InspireMD reported last 12-month revenue of $10M and negative EBITDA of ($44M).
In the same LTM period, InspireMD generated $2M in gross profit, ($44M) in EBITDA losses, and had net loss of ($55M).
Revenue (LTM)
InspireMD P&L
In the most recent fiscal year, InspireMD reported revenue of $9M and EBITDA of ($38M).
InspireMD is unprofitable as of last fiscal year, with gross margin of 30%, EBITDA margin of (419%), and net margin of (543%).
Financial data powered by Morningstar, Inc.
InspireMD Stock Performance
InspireMD has current market cap of $47M, and enterprise value of $9M.
Market Cap Evolution
InspireMD's stock price is $1.01.
InspireMD share price decreased by 15.1% in the last 30 days, and by 60.5% in the last year.
InspireMD has an EPS (earnings per share) of $-1.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9M | $47M | 0.0% | -15.1% | -43.3% | -60.5% | $-1.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInspireMD Valuation Multiples
InspireMD trades at 0.9x EV/Revenue multiple, and (0.2x) EV/EBITDA.
EV / Revenue (LTM)
InspireMD Financial Valuation Multiples
As of May 26, 2026, InspireMD has market cap of $47M and EV of $9M.
InspireMD has a P/E ratio of (0.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified InspireMD Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


InspireMD Margins & Growth Rates
InspireMD grew revenue by 16% and EBITDA by 42% in the last fiscal year.
In the most recent fiscal year, InspireMD reported gross margin of 30%, EBITDA margin of (419%), and net margin of (543%).
InspireMD Margins
InspireMD Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
InspireMD Operational KPIs
InspireMD's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.6M for the same period.
InspireMD's Rule of 40 is (499%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
InspireMD's Rule of X is (476%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
InspireMD Competitors
InspireMD competitors include Mentice, HeartBeam, OssDsign, Elutia, Nutriband, Singular Health, SciBase Holding, Baumer, Baird Medical Investment and K Pharma.
Most InspireMD public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.4x | 1.3x | 88.9x | 33.1x | |||
| — | 119.6x | (2.2x) | — | |||
| 1.5x | 1.6x | (7.4x) | (6.7x) | |||
| 2.1x | 2.1x | (2.0x) | (1.8x) | |||
| 14.6x | 14.6x | (5.0x) | — | |||
| 249.9x | — | (8.3x) | — | |||
| 10.5x | 8.4x | (5.2x) | (5.6x) | |||
| 0.8x | — | 3.8x | — | |||
This data is available for Pro users. Sign up to see all InspireMD competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout InspireMD
| When was InspireMD founded? | InspireMD was founded in 2008. |
| Where is InspireMD headquartered? | InspireMD is headquartered in United States. |
| How many employees does InspireMD have? | As of today, InspireMD has over 86 employees. |
| Who is the CEO of InspireMD? | InspireMD's CEO is Marvin Slosman. |
| Is InspireMD publicly listed? | Yes, InspireMD is a public company listed on Nasdaq. |
| What is the stock symbol of InspireMD? | InspireMD trades under NSPR ticker. |
| When did InspireMD go public? | InspireMD went public in 1997. |
| Who are competitors of InspireMD? | InspireMD main competitors include Mentice, HeartBeam, OssDsign, Elutia, Nutriband, Singular Health, SciBase Holding, Baumer, Baird Medical Investment, K Pharma. |
| What is the current market cap of InspireMD? | InspireMD's current market cap is $47M. |
| What is the current revenue of InspireMD? | InspireMD's last 12 months revenue is $10M. |
| What is the current revenue growth of InspireMD? | InspireMD revenue growth (NTM/LTM) is 57%. |
| What is the current EV/Revenue multiple of InspireMD? | Current revenue multiple of InspireMD is 0.9x. |
| Is InspireMD profitable? | No, InspireMD is not profitable. |
| What is the current EBITDA of InspireMD? | InspireMD has negative EBITDA and is not profitable. |
| What is InspireMD's EBITDA margin? | InspireMD's last 12 months EBITDA margin is (461%). |
| What is the current EV/EBITDA multiple of InspireMD? | Current EBITDA multiple of InspireMD is (0.2x). |
| How many companies InspireMD has acquired to date? | InspireMD hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies InspireMD has invested to date? | InspireMD hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to InspireMD
Lists including InspireMD
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.